In Brief: Cambridge Biotech
Executive Summary
Cambridge Biotech: Appoints Alison Taunton-Rigby, PhD, to president and CEO, the company announces April 7. Taunton-Rigby was most recently CEO of privately-held Cambridge Mass. biotech company Mitotix, which she left in December, and previously served as senior VP of Genzyme and as head of the Massachusetts Biotechnology Council. Cambridge Biotech also names interim CEO Jeffrey Deaver to chairman of the board replacing John Scott who remains as director and chairman emeritus...